Ra. Harris et al., PREVENTION OF RECURRENCES OF EROSIVE REFLUX ESOPHAGITIS - A COST-EFFECTIVENESS ANALYSIS OF MAINTENANCE PROTON PUMP INHIBITION, The American journal of medicine, 102(1), 1997, pp. 78-88
PURPOSE: TO determine the cost-effectiveness of three management strat
egies for healed erosive reflux esophagitis: maintenance therapy with
a proton pump inhibitor (PPI) from the outset; no maintenance therapy
unless a patient's symptoms recur once over a year; and no maintenance
therapy unless a patient's symptoms recur twice over a year. MATERIAL
S AND METHODS: Decision analysis using data from randomized trials of
lansoprazole, case series, and expert opinion. RESULTS: For patients w
ith grade 4 esophagitis, maintenance from the outset is the most effic
ient approach. For all other patients, providing maintenance PPI after
a patient experiences two recurrences is the least costly but least e
ffective approach. The other two approaches prevent more recurrences:
waiting to initiate maintenance therapy until symptoms recur once requ
ires an additional $73 for each recurrence prevented whereas maintenan
ce PPI from the outset requires an additional $819 for each recurrence
prevented. Maintenance therapy from the outset is cost effective if s
ymptoms of esophagitis cause a 22% or greater decrement in quality of
life (using $50,000 per quality-adjusted life year gained as a cost-ef
fectiveness definition). However, withholding maintenance until the ti
me of a first recurrence is cost effective if symptoms cause a 2% or g
reater decrement in quality of life. CONCLUSION: For grades 2 and 3 es
ophagitis, providing maintenance therapy after a patient experiences a
further recurrence is a preferred option that appears cost-effective
across a wide array of assumptions. Maintenance therapy from the outse
t, however, appears cost-effective only for those patients who report
a significant decline in quality of life associated with esophagitis o
r for those patients with baseline grade 4 esophagitis. (C) 1997 by Ex
cerpta Medica, Inc.